23.01.2022, 673 Zeichen

Marinomed: Marinomed Biotech AG, an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, today announced that Dr. Cornelia Kutzer has been appointed as Chief Business Officer (CBO) of the company. As CBO, Dr. Kutzer will be responsible for further expanding Marinomed’s network of strategic partnerships both for product development and distribution in the therapeutic areas infectious diseases and immunology with an emphasis on ophthalmological indications.
Marinomed Biotech: weekly performance: 3.56%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (21/01/2022)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #856: ATX TR 10.000, wie wärs mir einer PK? Wir haben O-Töne zum Rekord und Palfinger erwähnt Rheinmetall

Bildnachweis

Aktien auf dem Radar:Strabag, Frequentis, Porr, EuroTeleSites AG, Pierer Mobility, Agrana, OMV, Semperit, CA Immo, Immofinanz, Verbund, Andritz, AT&S, Bawag, BTV AG, Erste Group, Gurktaler AG VZ, Lenzing, Palfinger, Österreichische Post, voestalpine, Wienerberger, Wolford, Zumtobel, BKS Bank Stamm, Oberbank AG Stamm, Austriacard Holdings AG, Amag, EVN, Flughafen Wien, Telekom Austria.

---